  Background: The aim of this study is to use bioinformatics to discover the
biomarkers associated with patients with Pancreatic Ductal
Adenocarcinoma(PDAC).
  Material and Methods: GSE28735, GSE15471, and GSE62452 are gene microarray
datasets drived from the GEO database, included 153 PDAC samples and 145 normal
samples. By analyzing both Gene Ontology (GO) and the Kyoto Encyclopedia of
Genes (KEGG), for screening DEGs has provided information about their
biological function. Protein-protein interactions (PPI) of DEGs were analyzed
using the Search Tool for the Retrieval of Interacting Genes database (STRING)
and visualized by Cytoscape. UALCAN was also used to perform prognostic
analyses.
  Results: In Pancreatic ductal adenocarcinoma, we discovered 2264 upregulated
DEGs (uDEGs) and 723 downregulated DEGs (dDEGs). The Gene Ontology (GO)
indicated that extracellular matrix organization, extracellular structure
organization, collagen catabolic process and also the uDEGs are enriched in
focal adhesion, PI3K-Akt signaling pathway, ECM-receptor interaction by KEGG
analysis. The top ten hub genes were identified from the PPI network: COL1A1,
COL3A1, COL1A2, FN1, COL5A2, ITGA3, FBN1, MET, COL6A3, and BGN. These 10 hub
genes are highly upregulated in pancreatic ductal adenocarcinoma, according to
GEPIA research. The UALCAN prognostic analysis of the 10 hub genes revealed
that two of the elevated genes, ITGA3 and MET, significantly shortened PDAC
patient survival time. Pancreatic ductal adenocarcinoma is linked to Focal
adhesion, the PI3K-Akt signaling pathway, and ECM-receptor interaction,
according to Module analysis from the PPI network.
  Conclusion: This investigation identified hub genes and important signal
pathways, which adds to our knowledge of molecular mechanisms and could be
exploited as diagnostic and therapeutic biomarkers for Pancreatic ductal
adenocarcinoma.
